Literature DB >> 10155559

Technical and clinical experience with protein A immunoadsorption columns.

M Belàk, H Borberg, C Jimenez, K Oette.   

Abstract

Protein A adsorption (Immunosorba, Excorim, Sweden) is a potent tool for the rapid removal of antibodies from the circulation. In comparison to conventional plasma exchange therapy, Protein A adsorption offers the advantage of processing large amounts of plasma, removing up to 87% of the initial level of IgG in one session without a clinically significant loss of fibrinogen. So far 61 treatments have been carried out in our department without serious side effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 10155559     DOI: 10.1016/0955-3886(94)90174-0

Source DB:  PubMed          Journal:  Transfus Sci        ISSN: 0955-3886


  8 in total

1.  Antibody-Mediated Rejection: A Review.

Authors:  Jorge Carlos Garces; Sixto Giusti; Catherine Staffeld-Coit; Humberto Bohorquez; Ari J Cohen; George E Loss
Journal:  Ochsner J       Date:  2017

Review 2.  Rational clinical trial design for antibody mediated renal allograft injury.

Authors:  Shaifali Sandal; Martin S Zand
Journal:  Front Biosci (Landmark Ed)       Date:  2015-01-01

3.  Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications.

Authors:  Kornelius Fuchs; Silke Rummler; Wolfgang Ries; Matthias Helmschrott; Jochen Selbach; Friedlinde Ernst; Christian Morath; Adelheid Gauly; Saynab Atiye; Manuela Stauss-Grabo; Mareike Giefer
Journal:  Ther Apher Dial       Date:  2021-05-06       Impact factor: 2.195

4.  Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies.

Authors:  Alexander J Davies; Janev Fehmi; Makbule Senel; Hayrettin Tumani; Johannes Dorst; Simon Rinaldi
Journal:  J Clin Med       Date:  2020-06-27       Impact factor: 4.241

Review 5.  Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs-A Systematic Review.

Authors:  Leoni Rolfes; Steffen Pfeuffer; Tobias Ruck; Nico Melzer; Marc Pawlitzki; Michael Heming; Marcus Brand; Heinz Wiendl; Sven G Meuth
Journal:  J Clin Med       Date:  2019-10-04       Impact factor: 4.241

6.  Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma-A case report.

Authors:  Philipp Gauckler; Johannes Leierer; Florian Kocher; Clemens Feistritzer; Wolfgang Willenbacher; Eberhard Gunsilius; Dominik Wolf; Hannes Neuwirt; Gert Mayer; Andreas Kronbichler
Journal:  J Clin Apher       Date:  2020-03-06       Impact factor: 2.821

7.  Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial.

Authors:  Johannes Dorst; Tanja Fangerau; Daniela Taranu; Pia Eichele; Jens Dreyhaupt; Sebastian Michels; Joachim Schuster; Albert C Ludolph; Makbule Senel; Hayrettin Tumani
Journal:  EClinicalMedicine       Date:  2019-11-14

8.  Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation.

Authors:  Johan Noble; Antoine Metzger; Hamza Naciri Bennani; Melanie Daligault; Dominique Masson; Florian Terrec; Farida Imerzoukene; Beatrice Bardy; Gaelle Fiard; Raphael Marlu; Eloi Chevallier; Benedicte Janbon; Paolo Malvezzi; Lionel Rostaing; Thomas Jouve
Journal:  J Clin Med       Date:  2021-03-23       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.